United States · Who invested in Tigris Pharmaceuticals?
Tigris Pharmaceuticals's investors include Riverbank Capital Securities, NGN Capital, Wexford Capital, Sonostar Ventures and Neil Flanzraich, and 1 more on record.
2007200820092010
$16MSeries B$6.5MSeries CUnited States · Series C startup
Who invested in Tigris Pharmaceuticals
2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Tigris Pharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$23Mraised across 2 rounds since 2007, from 2 sources
$16MSeries B$6.5MSeries C
- Latest round
- Series C, $6.5MSept 2010
- Biggest round
- $16MSeries B · Jan 2007
- Investors
- 6
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $16M Jan 2007
- Biggest round
- $16M Series B · Jan 2007
- Between rounds
- 3.7 years from the last two
The rounds
- Sept 2010Series C$6.5M3 new1 returning
Riverbank Capital Securities
Sonostar Ventures- Neil Flanzraich
- Wexford Spectrum Investors
Reported by tigrispharma.com
- Jan 2007Series B$16M3 new
From a historical funding record
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series B2007Series C2010Riverbank Capital SecuritiesNGN Capital
Wexford CapitalSonostar VenturesNeil FlanzraichWexford Spectrum Investors
Riverbank Capital SecuritiesNGN CapitalWexford CapitalSonostar VenturesNeil FlanzraichWexford Spectrum InvestorsEveryone who backed them
NGN CapitalVC firm1round
Neil Flanzraichno record of our own yet1round
Wexford Spectrum Investorsno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Tigris Pharmaceuticals
How much has Tigris Pharmaceuticals raised?
Tigris Pharmaceuticals has raised $23M across 2 rounds since 2007.
When did Tigris Pharmaceuticals last raise?
Tigris Pharmaceuticals's most recent round was a Series C of $6.5M in Sept 2010.
What was Tigris Pharmaceuticals's biggest round?
Tigris Pharmaceuticals's largest round on record is $16M (Series B), in Jan 2007.
Who backed Tigris Pharmaceuticals first?
Tigris Pharmaceuticals's first round on record, in Jan 2007, was backed by NGN Capital, Wexford Capital and Riverbank Capital Securities.
What stage is Tigris Pharmaceuticals at?
Tigris Pharmaceuticals's latest named round is a Series C, in Sept 2010.
Where is Tigris Pharmaceuticals based?
Tigris Pharmaceuticals is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.